← Leaderboards
Jason M Glanz
Kaiser Foundation Research Institute
$7,837,583
Attributed
$12,851,607
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2007–22$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,762,483 · 5
AHRQ$2,289,396 · 2
CDC$799,728 · 1
By mechanism
R01$10,742,698 · 4
U01$799,728 · 1
K01$534,162 · 1
R56$475,024 · 1
R21$299,995 · 1
Top collaborators
- Ingrid A Binswanger16 shared
- Amanda F Dempsey5 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Lynn Larson Debar$40,780,655
- David H Smith$2,518,346
- Mark Christopher Hornbrook$5,605,661
- Andrea Jean Cook$1,348,819
- Gregory E Simon$47,932,393
Others in their field
Top investigators on “Provider”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,562,893,282
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$697,762,662
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$562,749,658
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
ProviderBaseColoradoUnited StatesSafetyMedicalOverdoseElectronic Health RecordHealth SystemOpioidSurveysProgramsPharmaceutical PreparationsResearch PersonnelPainPublic HealthCessation Of LifeInterviewPatient PopulationRandomizedPrescription OpioidAffectGuidelinesPopulations At Risk
Grant awards (32)
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$708,769
R01 · FY2022 · DA
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$541,951
R01 · FY2021 · DA
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$163,172
R01 · FY2021 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$633,265
R01 · FY2020 · DA
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$549,946
R01 · FY2020 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$615,456
R01 · FY2019 · DA
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$588,255
R01 · FY2019 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$161,892
R01 · FY2019 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$122,232
R01 · FY2019 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$640,139
R01 · FY2018 · DA
The REDIVAC Study - Reducing Delay In Vaccination of Children Study$493,132
R01 · FY2018 · HD
Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies$400,000
U01 · FY2018 · CE
Diversity Supplement to R01DA042059$122,232
R01 · FY2018 · DA
The Safety and Impact of Expanded Access to Naloxone in Health Systems$652,539
R01 · FY2017 · DA
The REDIVAC Study - Reducing Delay In Vaccination of Children Study$480,361
R01 · FY2017 · HD
Applying Big Data Analytics to Study the Impact of Opioid Prescribing Policy Changes on Prescribing Behavior and Overdose Outcomes$475,024
R56 · FY2017 · DA · contact PI
Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies$399,728
U01 · FY2017 · CE
The Safety and Impact of Expanded Access to Naloxone in Health Systems$632,432
R01 · FY2016 · DA
The REDIVAC Study - Reducing Delay In Vaccination of Children Study$476,196
R01 · FY2016 · HD
The REDIVAC Study - Reducing Delay In Vaccination of Children Study$594,174
R01 · FY2015 · HD
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website$495,470
R01 · FY2015 · HS · contact PI
The REDIVAC Study - Reducing Delay In Vaccination of Children Study$577,154
R01 · FY2014 · HD
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website$497,986
R01 · FY2014 · HS · contact PI
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website$498,253
R01 · FY2013 · HS · contact PI
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website$497,692
R01 · FY2012 · HS · contact PI
An evaluation of an interactive social media website for parents who are concerne$134,694
R21 · FY2011 · HS · contact PI
Vaccine Refusal: Clinical Impact and Parental Attitudes$101,744
K01 · FY2011 · AI · contact PI
An evaluation of an interactive social media website for parents who are concerne$165,301
R21 · FY2010 · HS · contact PI
Vaccine Refusal: Clinical Impact and Parental Attitudes$97,234
K01 · FY2010 · AI · contact PI
Vaccine Refusal: Clinical Impact and Parental Attitudes$114,730
K01 · FY2009 · AI · contact PI
Vaccine Refusal: Clinical Impact and Parental Attitudes$111,297
K01 · FY2008 · AI · contact PI
Vaccine Refusal: Clinical Impact and Parental Attitudes$109,157
K01 · FY2007 · AI · contact PI